GSK (GSK LN) has received expanded US age indication approval in the US for Arexvy
Newsquawk Staff ·
GSK (GSK LN) has received expanded US age indication approval in the US for Arexvy.
What it means
GSK has secured expanded US age indication approval for its vaccine Arexvy, which indicates strong regulatory confidence in the product and bodes well for potential market expansion. This approval could enhance GSK's competitive positioning in the vaccine space, potentially leading to increased revenue projections and positive sentiment around its stock performance. Watch for any shifts in analyst ratings or sector positioning as this news develops.
- Al-Mayadeen correspondent in Iran says Iranian officials believe that Trump wants to bring the nuclear issue into the negotiations, which Iran rejects
- Daily US Conference Calendar - 28th October 2026: JNJ, BA, CAT
- Eli Lilly’s (LLY) retatrutide delivered greater A1C reduction and more than double the weight loss of Novo Nordisk’s (NOVOB DC) Ozempic at its highest approved dose in head-to-head trial
- UK confirms it will be removing the standing charge on gas bills. Ofgem will be directed to do this in 2027, or as soon as possible
- Santander (SAN SM) Q3 (EUR) net 3.43bln (exp. 3.41bln), rev. 16.0bln (prev. 15.3bln Y/Y)
Related headlines
- Senior US Treasury trade official Eric Ettorre will leave to join Netflix (NFLX), reports Axios1 hour ago
- US Midterms (6 days out): Florida flips to a Republican early-vote lead and Kansas narrows further; Crystal Ball shifts House and Senate races towards Democrats1 hour ago
- US President Trump says there will be a meeting with Russian President Putin and Ukrainian President Zelensky set up soon, while Trump says there will be a meeting on disarmament during Asia trip10 hours ago
- JPMorgan Chase (JPM) reportedly faces an additional GBP 100-150mln tax bill following the UK government's decision to double the corporation tax surcharge on banks, potentially jeopardising plans for its new London headquarters, Sky News reports26 min ago
- [MARKET UPDATE] Limited Gilt reaction on the Chancellor's speech. Upside in Gilts on the DMO remit, size as expected and marked skew away from long-end. OBR commentary then pared some of this.1 hour ago
- Ukrainian President Zelensky says negotiations between Ukraine, Russia and the US could take place as early as November 10th1 hour ago
- Israeli election results show Netanyahu's bloc with 53 seats, Eisenkot's bloc with 47 and Arab parties with 19, following the counting of all votes excluding double-envelope ballots, i24 reports2 hours ago
- UK PM Burnham declines to rule out another Brexit referendum at PMQs2 hours ago
- Atomic Energy Organization of Iran Spokesman says protocol for building small reactors with Russia is being finalized3 hours ago
- Russian Deputy PM Novak says they are open to work with US partners on energy, but there are no current discussions around a return to specific projects4 hours ago
- Ukrainian President Zelensky says Western powers could eventually discuss Russia's demands for security guarantees, but insists Ukraine's own security needs must be addressed first4 hours ago
- [MARKET ANALYSIS] Crude grinds higher, Dutch TTF remains just under EUR 100/MWh, metals subdued 5 hours ago
- [MARKET ANALYSIS] Contained, but a bearish skew, across fixed income into the UK Budget and FOMC5 hours ago
- [MARKET ANALYSIS] Antipodeans diverge as AUD saw strong CPI and NZD slumped on a surprise RBNZ hold, DXY awaits the Fed5 hours ago
- [MARKET ANALYSIS] A busy morning for EU banking names, with tech stocks supported by upbeat SK Hynix earnings5 hours ago